Wolfram-Hubertus Zimmermann

Wolfram-Hubertus Zimmermann

DZHK (German Center for Cardiovascular Research) partner site, Goettingen

Affiliated withDZHK (German Center for Cardiovascular Research) partner site, GoettingenCenter for Neurodegenerative Diseases (DZNE)Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP)

+2

Research Area

Biography

1991-1998 Medical School; University Medical Center Hamburg, Germany

Clinical electives at:

Duke University Medical School in Durham, North Carolina, USA

Beth Israel Deaconess Medical Center and Mount Auburn Hospital, Harvard Medical School, Boston, Massachusetts, USA

Groote Schuur Hospital, University of Cape Town, South-Africa

1994/1998 United States Medical Licensing Examination (USMLE) step 1/2

1998 – 2001 Postgraduate studies in “Molecular Biology”, University Hamburg

1999 – 2001 Resident (Clinical Pharmacology), University Erlangen-Nuremberg

2001 – 2003 Resident & Lecturer (Clinical Pharmacology), University Erlangen-Nuremberg

2003 – 2004 Lecturer & Staff Scientist (Pharmacology), University of Hamburg

2004 – 2008 Assistant professor (Juniorprofessor; Tissue Engineering), University Hamburg

2006 Board certification in Pharmacology and Toxicology

2007 Habilitation and Venia Legendi for Pharmacology and Toxicology

since 2008 W3-Professor & Director, Department of Pharmacology and Toxicology, University Medical Center Georg-August University Göttingen

JoVE Journal Publications

ArticleTotal : 1
Year
Fibroblast Derived Human Engineered Connective Tissue for Screening Applications
Publication title

Cited by 6

2021

Other Publications

Article
Year
Cardiac tissue engineering: implications for pediatric heart surgery.

Pediatric cardiology| PubMed ID: 19319461

2009
2010
Modeling myocardial growth and hypertrophy in engineered heart muscle.

Trends in cardiovascular medicine| PubMed ID: 23953977

2014
[Individualized stem cell therapy].

Herz| PubMed ID: 24589843

2014
2015
2015
2015
Mechanical stimulation in the engineering of heart muscle.

Advanced drug delivery reviews| PubMed ID: 26362920

2016
New Biologics for the Modulation of Post-Infarct Remodeling: Matricryptins.

Journal of the American College of Cardiology| PubMed ID: 26383725

2015
Strip and Dress the Human Heart.

Circulation research| PubMed ID: 26837739

2016
Translating Myocardial Remuscularization.

Circulation research| PubMed ID: 28104769

2017
2017
Myocardial Tissue Engineering for Regenerative Applications.

Current cardiology reports| PubMed ID: 28752277

2017
2017
Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery.

Annual review of pharmacology and toxicology| PubMed ID: 29029591

2018
2018
Highlighting the Field of Cardiovascular Regenerative Medicine.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 29934254

2018
Engineered Nanoparticles Prevent Dilation of Abdominal Aortic Aneurysms.

Journal of the American College of Cardiology| PubMed ID: 30466518

2018
2019
Cardiac macrotissues-on-a-plate models for phenotypic drug screens.

Advanced drug delivery reviews| PubMed ID: 30902615

2019
Physics meets medicine - At the heart of active matter.

Progress in biophysics and molecular biology| PubMed ID: 30980833

2019
A scale model of the human ventricle.

Nature biomedical engineering| PubMed ID: 31015732

2018
KLF15-Wnt-Dependent Cardiac Reprogramming Up-Regulates SHISA3 in the Mammalian Heart.

Journal of the American College of Cardiology| PubMed ID: 31582141

2019
2021
2020
2020
Engineered Heart Muscle Models in Phenotypic Drug Screens.

Handbook of experimental pharmacology| PubMed ID: 33136187

2021
2021